Ozempic Generics: A Promise of Affordable Diabetes Treatment

Tuesday, 17 September 2024, 17:00

Ozempic generics can be produced for less than $100 a month, claims Sen. Bernie Sanders, challenging the $969 U.S. price. Major generics CEOs agree on this possibility. This announcement precedes a Senate health committee hearing next week.
LivaRava_Medicine_Default.png
Ozempic Generics: A Promise of Affordable Diabetes Treatment

Ozempic Generics Could Revolutionize Diabetes Treatment Affordability

During a recent expert roundtable, Senator Bernie Sanders revealed that generics companies are capable of producing and selling Ozempic for under $100 per month, significantly lower than the current price of almost $1,000 in the United States. This statement comes ahead of an upcoming Senate health committee hearing where Novo Nordisk CEO Lars Jørgensen will testify regarding pricing practices.

Senator Sanders' Critique of Current Pricing

  • Sanders highlighted absurd pricing discrepancies between the U.S. and other countries, with Canadian patients paying about $155 and German patients paying around $59 for the same medication.
  • According to Sanders, the exorbitant costs of Ozempic and its sister drug Wegovy could potentially bankrupt Medicare and Medicaid.
  • A recent Journal of the American Medical Association study indicated that injectable semaglutide could be manufactured profitably for less than $5 per month, underscoring the potential for lower pricing.

Looking Ahead: The Future of Diabetes Medication Pricing

As discussions around pharmaceutical pricing intensify, both Sanders and President Joe Biden have called out the high prices of diabetes treatments, pushing for reform in the healthcare system.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the most accurate and current medical news. Stay updated and deepen your understanding of medical advancements effortlessly.

Subscribe